Skip to: site menu | section menu | main content
Current treatments for leukemia, such as chemotherapy and radiation damage
healthy cells and tissues and can produce unwanted side effects for many
years afterward. However the new compound, called C-3-R,
selectively kills leukemia cells while showing no discernible toxicity
against healthy cells.
Researchers found that the compund caused about 50 percent of a human leukemia
cell line to undergo programmed cell death within about 18 hours of treatment
at low doses. When they more than doubled the concentration of C-3-R, all
of the leukemia cells died.
The results indicate that C-3-R has the promising potential to be used
in leukemia therapy with the advantages of being highly selective against
cancer cells.
Leukemia is a number of related cancers that start in the blood-forming
cells of the bone marrow. It occurs when there is an excess of abnormal
white blood cells.
back to Leukemia News Home
NOTE: This web site is designed for educational purposes only and is not engaged in rendering medical advice. The information provided through this site should not be used for diagnosing or treating a health problem or a disease. If you have or suspect you may have a health problem, you should consult your health care provider